Title
Category
Credits
Event date
Cost
$0.00
Health Care Attorney Scott Kessenick will discuss licensing issues that can arise for California Physicians. This presentation will provide an overview of California Medical Board investigations, including how they are triggered, and what rights you may have to prevent them. 
  • S.U.D
$0.00
Summary This activity is a recording of virtual session offered in March, 2021 through the California Residency Program Collaborative (CRPC) around improving Substance Use Disorder (SUD) services and includes a list of additional resources and a robust Q&A section.  Treating SUD - Linking with Community Services offers information, tools and resources to clinicians considering the addition of Medication Assisted Treatment (MAT) services for their patients.ResourcesResources mentioned during the roundtable discussion:
  • S.U.D
$0.00
Summary This activity is a recording of virtual session offered in March, 2021 through the California Residency Program Collaborative (CRPC) around improving Substance Use Disorder (SUD) services and includes a list of additional resources and a robust Q&A section.  Incorporating MAT into Practice – A Community Conversation offers learners an opportunity to listen in while more experienced MAT providers provide tips and tricks and discuss lessons learned throughout their career providing MAT services.
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objective:At the end of this session, learners should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objective:At the end of this session, learners should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objective:At the end of this session, learners should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, participants should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options.Learning Objectives:At the end of this session, learners should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, learners should be able to:
  • S.U.D
  • AAFP Prescribed
  • AMA PRA Category 1 Credit™
  • AOA Category 2-A
$0.00
This activity is part of CAFP's California Residency Program Collaborative around improving education, outreach and treatment for patients with substance use disorder disease, including stimulants and opioids, with a focus on medication assisted treatment options. Learning Objectives:At the end of this session, learners should be able to:

Pages